AVC (Meda Pharmaceuticals)


Welcome to the PulseAid listing for the AVC drug offered from Meda Pharmaceuticals. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Meda Pharmaceuticals
NON-PROPRIETARY NAME: sulfanilamide
SUBSTANCE NAME: SULFANILAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: VAGINAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-12-01
END MARKETING DATE: 0000-00-00


AVC HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAVC from Meda Pharmaceuticals
LABELER NAME: Meda Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 15(g/100g)
START MARKETING DATE: 2014-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0037-6631_17e55d0e-8126-4472-9333-d363612b422d
PRODUCT NDC: 0037-6631
APPLICATION NUMBER: NDA006530

Other SULFANILAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Jazz Pharmaceuticals Commercial Corp.AVC Vaginal
Meda PharmaceuticalsAVC